|
|
|
Saturday, March 17, 2012 — 7:00 p.m. — Convention Centre Ballroom D
|
- Minimizing Gray Zones in Diagnosis of Endocrine Lesions
|
|
Moderators:
|
George Kontogeorgos, Athens General Hospital, Athens, Greece and Vania Nose, University of Miami School of Medicine, Miami, FL
|
Click the button above to add this event to your Itinerary Planner...
| 7:00 |
Diagnostic Dilemmas in Adrenal Hyperplasia / Adenoma / Carcinoma - Anne Marie McNicol, UQCCR, Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia |
| 7:40 |
Interphase Among Normal, Hyperplastic and Neoplastic Parathyroids — A Modern Approach - Virginia LiVolsi, University of Pennsylvania, Philadelphia, PA |
| 8:20 |
Overlapping of Neuroendocrine Hyperplasia / Tumor / Carcinoma - Guenter Kloppel, Technische Universitat Munchen, Klinikum rechts der Isar, Munchen, Deutschland |
| 9:00 |
Morphologic and Molecular Gray Zones in Thyroid Proliferative Disorders - Sylvia L. Asa, University of Toronto, Toronto, Ontario, Canada |
| 9:40 | General Discussion |
The topic was selected because it is well known that some Endocrine Pathology lesions are difficult to diagnose as there is an overlapping in the sequence of normal parenchyma/hyperplasia/adenoma/carcinoma. In some instances there are lesions that by morphology and even by molecular techniques are morphologically similar, which may represent normal elements, hyperplastic conditions, benign, or malignant lesions. These “gray zones” in diagnosis of endocrine lesions represent a difficult and controversial task.
This symposium highlights problematic “gray zones” areas in the diagnosis of adrenal, thyroid, parathyroid and gastroenteropancreatic pathology, formulates a differential diagnosis, and discusses the histological characteristics and molecular markers of the endocrine lesions. This will provide clues leading to the identification of features that can helpful in the diagnosis of difficult endocrine lesions.
|
|
|
|
